← Leaderboards
Daniela Annenelie Bota
University Of California-Irvine
$3,732,045
Attributed
$6,597,714
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,597,714 · 3
By mechanism
R01$5,731,338 · 2
K08$866,376 · 1
Top collaborators
- Kalpna Gupta11 shared
- Bhaskar Chandra Das9 shared
Most similar at University Of California-Irvine
Same institution · by research overlap
- Hamid Moradi$185,622
Others in their field
Top investigators on “Mitochondria”
- Bruce M Spiegelman · Dana-Farber Cancer Inst$30,163,696
- Shi Du Yan · Columbia University Health Sciences$29,685,201
- Peipei Ping · University Of California Los Angeles$27,344,561
- Mary McGrae McDermott · Northwestern University$25,752,019
- Vamsi Krishna Mootha · Massachusetts General Hospital$23,004,991
- Kenneth D. Tew · Fox Chase Cancer Center$22,000,362
Research focus
MitochondriaClinical TrialsMitochondrial DnaIn VivoIn VitroChemotherapyMalignant NeoplasmsChemotherapeutic AgentBrainNovel TherapeuticsBioenergeticsSmall Interfering RnaPathway InteractionsToxic EffectMolecularFda ApprovedNovel StrategiesCell LineInhibitorDensityDendritic SpinesDiagnosisCancer PatientAdverse Effects
Grant awards (25)
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system$601,825
R01 · FY2025 · CA · contact PI
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system$82,514
R01 · FY2025 · CA · contact PI
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system$80,303
R01 · FY2025 · CA · contact PI
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system$574,826
R01 · FY2024 · CA · contact PI
Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma$399,338
R01 · FY2024 · NS · contact PI
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system$95,469
R01 · FY2024 · CA · contact PI
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system$82,514
R01 · FY2024 · CA · contact PI
Supplement to Promote Diversity: Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system$33,139
R01 · FY2024 · CA · contact PI
Supplement to Promote Diversity:Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system$18,319
R01 · FY2024 · CA · contact PI
Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma$9,145
R01 · FY2024 · NS · contact PI
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system$613,079
R01 · FY2023 · CA · contact PI
Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma$411,688
R01 · FY2023 · NS · contact PI
Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma$78,339
R01 · FY2023 · NS · contact PI
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system$616,655
R01 · FY2022 · CA · contact PI
Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma$411,688
R01 · FY2022 · NS · contact PI
Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma$78,339
R01 · FY2022 · NS · contact PI
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system$634,722
R01 · FY2021 · CA · contact PI
Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma$411,688
R01 · FY2021 · NS · contact PI
Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma$71,810
R01 · FY2021 · NS · contact PI
Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma$425,938
R01 · FY2020 · NS · contact PI
Mechanisms of Chemotherapy Induced Cognitive Defects$175,068
K08 · FY2015 · NS · contact PI
Mechanisms of Chemotherapy Induced Cognitive Defects$175,068
K08 · FY2014 · NS · contact PI
Mechanisms of Chemotherapy Induced Cognitive Defects$175,068
K08 · FY2013 · NS · contact PI
Mechanisms of Chemotherapy Induced Cognitive Defects$170,586
K08 · FY2012 · NS · contact PI
Mechanisms of Chemotherapy Induced Cognitive Defects$170,586
K08 · FY2011 · NS · contact PI